Take a holistic approach to genomic testing reimbursement
To get to the root of existing reimbursement problems, health plans should consider tackling genomic benefits management in a way that addresses test ordering and billing challenges.
Foundation Medicine, Epic partner to integrate genomic insights into EHR
As a result of the partnership, clinicians using Epic will be able to order Foundation Medicine's genomic profiling tests directly from the EHR and view results in the system, providing them with clinical decision support.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
NHS invests $300M in the development of new AI capabilities
The National AI lab is meant to support clinicians in efforts to estimate future needs of healthcare resources, identify the best sites of care for patients and help automate routine and administrative tasks to increase system efficiency.
23andMe gets FDA nod for new Colorectal cancer indication test
The company used its previous authorization for breast cancer genetic screening as a predicate for its 510(k) approval.
CMS gives a big boost to broad genomic tests by widening coverage for sequencing
Foundation Medicine and ThermoFisher Scientific are big beneficiaries of CMS widening its coverage and making a national coverage decision for next-generation sequencing of metastatic, Stage 3 or 4 and other cancers.
Guardant Health announced an almost $100M Series D round for its cancer blood test
The Redwood City, Calif.-based company has raised nearly $100 million in Series D financing led by OrbiMed Advisors.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
FDA launches precisionFDA, a platform for collaboration to increase DNA data
The FDA is embracing precision medicine with its new platform designed to allow scientists to share next-generation sequencing data.
GuardantHealth, Flatiron Health to link genomics, analytics for personalized cancer care
In a further sign of the convergence happening in healthcare technology, genomics company GuardantHealth is teaming with health IT and analytics vendor Flatiron Health to create a new platform to enable personalized cancer care.
Study: Customers of commercial genomic testing services understand results more than expected
For average people without a science or healthcare background, genetic testing results would seemingly be difficult to understand, but that might not be the case.